Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Alector Inc. (ALEC)

27.41   0.02 (0.07%) 02-26 16:00
Open: 27.57 Pre. Close: 27.39
High: 29.08 Low: 27
Volume: 427,420 Market Cap: 2156M
Alector, Inc., a clinical stage biotechnology company, focuses on developing therapies that harness the immune system to cure neurodegenerative diseases. Its products in Phase I clinical trial include AL001, a humanized recombinant monoclonal antibody for the treatment of frontotemporal dementia; and AL002 for the treatment of Alzheimer's disease. The company's preclinical stage products comprise AL101 for the treatment of multiple neurodegenerative disorders; and AL003 for the treatment of Alzheimer's disease. It also has 10 programs under research and development stage. The company was founded in 2013 and is headquartered in South San Francisco, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 29.116 - 29.224 29.224 - 29.311
Low: 26.723 - 26.852 26.852 - 26.956
Close: 27.215 - 27.416 27.416 - 27.576

Technical analysis

as of: 2020-02-26 4:25:32 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 35.62     One year: 41.97
Support: Support1: 21.71    Support2: 18.06
Resistance: Resistance1: 30.50    Resistance2: 35.93
Pivot: 30.26
Moving Average: MA(5): 28.50     MA(20): 29.71
MA(100): 20.14     MA(250): 19.46
MACD: MACD(12,26): 1.25     Signal(9): 2.02
Stochastic oscillator: %K(14,3): 9.08     %D(3): 19.83
RSI: RSI(14): 49.92
52-week: High: 35.93  Low: 13.64  Change(%): 39.9
Average Vol(K): 3-Month: 58433  10-Days: 52113

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
ALEC has closed above bottom band by 19.8%. Bollinger Bands are 56% wider than normal. The large width of the bands suggest high volatility as compared to ALEC's normal range. The bands have been in this wide range for 25 bars. This is a sign that the current trend might continue.

Headline News

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NasdaqGS
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 78.66
Shares Float (M) 39.37
% Held by Insiders 17.50
% Held by Institutions 62.30
Shares Short (K) 4280
Shares Short P. Month (K)

Stock Financials

EPS -1.930
Book Value (p.s.) 3.170
PEG Ratio -0.57
Profit Margin
Operating Margin -410.13
Return on Assets (ttm) -16.3
Return on Equity (ttm) -53.3
Qtrly Rev. Growth -58.5
Gross Profit (p.s.) -0.577
Sales Per Share
EBITDA (p.s.) -1.236
Qtrly Earnings Growth
Operating Cash Flow (M) -88.14
Levered Free Cash Flow (M) -48.58

Stock Valuations

P/E -14.20
P/E Growth Ratio
P/BV 8.65
P/S 53.74
P/CF -24.46

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.